Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | PGD | P52209 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1347333 | 1.00 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL625380 | 1.00 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL1131441 | 0.87 | USP2 (0.39) | USP2SLCO1B1CA4PGD | |
| SCHEMBL15233905 | 0.84 | USP2 (0.52) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| Potassium Ion SCHEMBL15233910 | 0.83 | USP2 (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL5790915 | 0.81 | PDE4A (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL5042 | 0.81 | PDE4A (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL671072 | 0.81 | PDE4A (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL185904 | 0.81 | PDE4A (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL5792603 | 0.81 | PDE4A (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 556 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313874-A1 | METHOD FOR PRODUCING LACTO-N-TETRAOSE AND LACTO-N-NEOTETRAOSE USING CORYNEBACTERIUM GLUTAMICUM | ADVANCED PROTEIN TECHNOLOGIES CORP. (KR) | 2025-10-09 | — | — | US | claimed |
| CN-119278266-A | Method for producing lactose-N-tetraose and lactose-N-new tetraose by using corynebacterium glutamicum | 高级蛋白质技术公司 | 2025-01-07 | — | — | CN | claimed |
| CN-117957316-A | Fucosyltransferase for converting lactose-N-disaccharide | 因比奥斯公司 | 2024-04-30 | — | — | CN | claimed |
| US-20240076704-A1 | PRODUCTION OF BIOPRODUCT IN A HOST CELL | INBIOSE N.V. (BE) | 2024-03-07 | — | — | US | claimed |
| CN-117157396-A | Cell production of sialylated di-and/or oligosaccharides | 因比奥斯公司 | 2023-12-01 | — | — | CN | claimed |
| CN-116323930-A | Cell production of sialylated di-and/or oligosaccharides | 因比奥斯公司 | 2023-06-23 | — | — | CN | claimed |
| CN-115960810-A | Whole cell for synthesizing chitosan oligosaccharide by double ways and production method thereof | 江苏海飞生物科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| EP-4045518-A1 | PRODUCTION OF BIOPRODUCT IN A HOST CELL | Inbiose N.V. (BE) | 2022-08-24 | — | — | EP | claimed |
| WO-2021074182-A1 | PRODUCTION OF BIOPRODUCT IN A HOST CELL | INBIOSE N.V. (BE) | 2021-04-22 | — | — | WO | claimed |
| US-20210087599-A1 | SIALYLTRANSFERASES AND THEIR USE IN PRODUCING SIALYLATED OLIGOSACCHARIDES | CHR. HANSEN A/S (DK) | 2021-03-25 | — | — | US | claimed |
| WO-2003015797-A1 | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF PAIN AND INFLAMMATION WITH A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND GLUCOSAMINE | PHARMACIA CORPORATION (US) | 2003-02-27 | — | — | WO | claimed |
| US-6472201-B1 | GROWING AND TESTING MICROORGANISMS IN A MULTITEST FORMAT WHICH UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2002-10-29 | — | — | US | claimed |
| WO-2002080934-A1 | A COMPOSITION COMPRISING GLUCOSAMINE FOR TREATING ANGIOGENESIS-DEPENDENT DISEASES | ANGIOLAB INC. (KR) | 2002-10-17 | — | — | WO | claimed |
| EP-1234882-A1 | GlmU POLYPEPTIDE AND DNA ENCODING THE POLYPEPTIDE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-08-28 | — | — | EP | claimed |
| JP-2002520067-A | — | — | 2002-07-09 | — | — | JP | claimed |
| EP-1095158-A1 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE | DCV, INC. d/b/a Bio-Technical Resources (US) | 2001-05-02 | — | — | EP | claimed |
| EP-1017401-A2 | TREATMENT AND PREVENTION OF IMMUNODEFICIENCY VIRUS INFECTION BY ADMINISTRATION OF NON-PYROGENIC DERIVATIVES OF LIPID A | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2000-07-12 | — | — | EP | claimed |
| WO-2000004182-A1 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE | DCV, INC. D/B/A BIO-TECHNICAL RESOURCES (US) | 2000-01-27 | — | — | WO | claimed |
| WO-1999015162-A2 | TREATMENT AND PREVENTION OF IMMUNODEFICIENCY VIRUS INFECTION BY ADMINISTRATION OF NON-PYROGENIC DERIVATIVES OF LIPID A | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 1999-04-01 | — | — | WO | claimed |
| WO-1995024497-A2 | ENZYMATIC PREPARATION OF POLYSACCHARIDES | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 1995-09-14 | — | — | WO | claimed |